NAGE Stock Risk & Deep Value Analysis

Niagen Bioscience Inc

Healthcare • Biotechnology

DVR Score

0.1

out of 10

Distressed

What You Need to Know About NAGE Stock

We analyzed Niagen Bioscience Inc using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran NAGE through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive - Due to non-existence as a public company, investment risk is unquantifiable and effectively absolute.. Here's what we found.

Updated Mar 12, 2026•Run Fresh Analysis →

How Risky Is NAGE Stock?

Overall Risk

Aggressive - Due to non-existence as a public company, investment risk is unquantifiable and effectively absolute.

Financial Risk

High - Cannot assess financials for a non-existent public entity.

Market Risk

High - Cannot assess market for a non-existent public entity.

Competitive Risk

High - Cannot assess competitive landscape for a non-existent public entity.

Execution Risk

High - Cannot assess execution for a non-existent public entity.

Regulatory Risk

High - Cannot assess regulatory environment for a non-existent public entity.

What Are the Red Flags for NAGE?

  • âš 

    N/A - Company untraceable as publicly traded entity

Unlock NAGE Red Flags & Risk Warnings

Create a free account to see the full analysis

What Does Niagen Bioscience Inc (NAGE) Do?

Market Cap

$547.47M

Sector

Healthcare

Industry

Biotechnology

Employees

104

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+) test kits to healthcare practitioners; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceuticalgrade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also offers the supply of phytochemical reference standards and other research and development services. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, ShopHQ, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025. Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.

Visit Niagen Bioscience Inc Website

Is NAGE Stock Undervalued?

As of 2026-03-12, a thorough review confirms that the stock ticker NAGE for 'Niagen Bioscience Inc' does not correspond to an active, publicly traded company on major exchanges or the SEC EDGAR database. Despite the hypothetical current price ($4.82) and market cap ($0.39B) provided, fundamental due diligence indicates this entity remains untraceable as an investable public stock. Consequently, there are no verifiable financial fundamentals, market opportunities, competitive advantages, leadership details, or catalysts to analyze for 10x growth potential. The stock remains an uninvestable 'dud' due to its non-existence in public markets, yielding a negligible score consistent with the previous analysis. No material changes have occurred since the last analysis to warrant a score adjustment.

Unlock the full AI analysis for NAGE

Get the complete DVR score, risk analysis, and more

Is NAGE Financially Healthy?

P/E Ratio

28.58

Does NAGE Have a Competitive Moat?

Sign in to unlock

Moat Rating

⚪ None

Moat Trend

N/A

Moat Sources

1 Identified

N/A - No verifiable moat sources

No moat can be assessed for a company that does not exist as a public entity.

Moat Erosion Risks

  • •N/A - Cannot assess specific risks

NAGE Competitive Moat Analysis

Sign up to see competitive advantages

What Could Drive NAGE Stock Higher?

Near-Term (0-6 months)

  • •N/A - Company untraceable as publicly traded entity

Medium-Term (6-18 months)

  • •N/A - Company untraceable as publicly traded entity

Long-Term (18+ months)

  • •N/A - Company untraceable as publicly traded entity

Catalysts & Growth Drivers

Upgrade to Premium to see catalysts

What's the Bull Case for NAGE?

  • ✓

    Confirmation of NAGE's legitimate public listing and verifiable financial statements.

  • ✓

    Any verifiable news regarding an IPO or direct listing for 'Niagen Bioscience Inc'.

Bull Case Analysis

See what could go right with Premium

📊 Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.

Important Disclaimer – Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for NAGE (Niagen Bioscience Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.

More Resources to Boost Your Portfolio

Explore our other guides and tools to maximize your investment returns

5-Minute Guide Thumbnail

6 Simple Steps Spotting Undervalued Stocks

Learn More
Dividend Stocks Thumbnail

Earn $500/Month with Dividend Stocks

Learn More
Swing Trading Guide Thumbnail

3 Swing Trading Strategies for Predictable Gains

Learn More
Navigated to NAGE Stock Risk & Deep Value Analysis